TRINITY BIOTECH PLC (TRIBXXXX)
Institutional ownership reported to the SEC as of Q4 2023, across 21 quarters.
20
Reporting holders
$320.1K
Reported value
0.1%
Held as options
+5
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2023 | 20 | $320.1K | 742,798 | 5 | 1 | 3 | 0.1% |
| Q3 2023 | 15 | $508.9K | 692,771 | 1 | 0 | 2 | 0.0% |
| Q2 2023 | 15 | $722.8K | 754,232 | 2 | 1 | 0 | 0.6% |
| Q1 2023 | 16 | $801.4K | 839,696 | 2 | 1 | 3 | 0.7% |
| Q4 2022 | 15 | $913.1K | 922,276 | 3 | 1 | 4 | 0.0% |
| Q3 2022 | 19 | $7.5M | 7,015,017 | 2 | 2 | 6 | 0.3% |
| Q2 2022 | 19 | $8.9M | 7,294,511 | 3 | 1 | 7 | 0.0% |
| Q1 2022 | 22 | $9.6M | 9,018,907 | 3 | 5 | 7 | 0.2% |
| Q4 2021 | 20 | $7.9M | 5,412,150 | 2 | 5 | 4 | 1.7% |
| Q3 2021 | 22 | $12.4M | 5,515,826 | 3 | 5 | 7 | 3.6% |
| Q2 2021 | 28 | $17.6M | 5,664,514 | 3 | 6 | 6 | 5.2% |
| Q1 2021 | 32 | $21.4M | 5,404,173 | 9 | 2 | 11 | 5.1% |
| Q4 2020 | 25 | $23.6M | 5,936,182 | 6 | 6 | 10 | 4.1% |
| Q3 2020 | 21 | $12.9M | 6,300,475 | 4 | 7 | 4 | 1.2% |
| Q2 2020 | 24 | $16.6M | 7,315,374 | 9 | 5 | 5 | 3.7% |
| Q1 2020 | 20 | $9.7M | 8,778,536 | 1 | 4 | 7 | 0.0% |
| Q4 2019 | 23 | $10.8M | 10,436,623 | 3 | 6 | 5 | 0.0% |
| Q3 2019 | 24 | $12.9M | 10,629,465 | 2 | 3 | 8 | 0.0% |
| Q2 2019 | 32 | $20.2M | 11,818,645 | 3 | 7 | 10 | 0.0% |
| Q1 2019 | 35 | $37.3M | 13,086,618 | 0 | 9 | 12 | 0.0% |
| Q4 2018 | 38 | $30.3M | 13,223,666 | 0 | 0 | 1 | 0.0% |